Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Colao

Showing results (361-370 of 391) with videos related to

Pageof 40
Sort By:
Journal of Endocrinological Investigation|April 11, 2008
The biological characterization of neuroendocrine tumors: the role of neuroendocrine markersP Ferolla, A Faggiano, G Mansueto, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Pasireotide versus octreotide in acromegaly: a head-to-head superiority studyA Colao, M D Bronstein, P Freda, et al.
European Journal of Neurology|December 17, 2016
Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon β-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosisR Lanzillo, C Di Somma, M Quarantelli, et al.
Alimentary Pharmacology & Therapeutics|September 17, 2015
Letter: the response to somatostatin analogues in neuroendocrine tumours is influenced by the Ki67 scoreA Faggiano, A C Carratù, E Guadagno, et al.
Journal of Endocrinological Investigation|January 18, 2022
Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control studyT Feola, G Puliani, F Sesti, et al.
Pituitary|October 19, 2022
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) studyH Masri Iraqi, E Pigarova, S Zacharieva, et al.
Clinical Endocrinology|January 22, 2014
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumoursV Ramundo, M Del Prete, V Marotta, et al.
Endocrine|June 21, 2020
Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey databaseV Amodru, P Petrossians, A Colao, et al.
European Journal of Endocrinology|November 13, 2013
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patientsM Filopanti, A M Barbieri, G Mantovani, et al.
Journal of Endocrinological Investigation|September 8, 2023
Circulating myomiRNAs as biomarkers in patients with Cushing's syndromeC Pivonello, R Patalano, C Simeoli, et al.
Pageof 40

Showing results (361-370 of 391) with videos related to

Sort By:
Pageof 40
Journal of Endocrinological Investigation|April 11, 2008
The biological characterization of neuroendocrine tumors: the role of neuroendocrine markersP Ferolla, A Faggiano, G Mansueto, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Pasireotide versus octreotide in acromegaly: a head-to-head superiority studyA Colao, M D Bronstein, P Freda, et al.
European Journal of Neurology|December 17, 2016
Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon β-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosisR Lanzillo, C Di Somma, M Quarantelli, et al.
Alimentary Pharmacology & Therapeutics|September 17, 2015
Letter: the response to somatostatin analogues in neuroendocrine tumours is influenced by the Ki67 scoreA Faggiano, A C Carratù, E Guadagno, et al.
Journal of Endocrinological Investigation|January 18, 2022
Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control studyT Feola, G Puliani, F Sesti, et al.
Pituitary|October 19, 2022
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) studyH Masri Iraqi, E Pigarova, S Zacharieva, et al.
Clinical Endocrinology|January 22, 2014
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumoursV Ramundo, M Del Prete, V Marotta, et al.
Endocrine|June 21, 2020
Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey databaseV Amodru, P Petrossians, A Colao, et al.
European Journal of Endocrinology|November 13, 2013
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patientsM Filopanti, A M Barbieri, G Mantovani, et al.
Journal of Endocrinological Investigation|September 8, 2023
Circulating myomiRNAs as biomarkers in patients with Cushing's syndromeC Pivonello, R Patalano, C Simeoli, et al.
Pageof 40